Hyaluronic Acid 200mg + Vitamin C | Deep Skin Hydration & Collagen-Synthesis Cofactor

200 mg of pharmaceutical-grade Hyaluronic Acid + 100 mg Vitamin C in every capsule — deep dermal hydration from inside the skin, plus the redox cofactor your collagen-synthesis enzymes literally cannot work without. Higher HA dose than most over-the-counter beauty capsules, third-party tested, vegan fermentation-derived, and formulated as a daily structural input — not a one-week cosmetic novelty.

The 30-second answer

• HA is a glycosaminoglycan that binds up to 1,000× its own weight in water — roughly 6 liters per gram in living tissue. Half of your body's total HA sits in the dermis. That's the molecule that keeps young skin plump, elastic, and visibly hydrated from below the surface.
• Skin HA halves between age 20 and 40 and continues falling after that (Stern, Eur J Cell Biol 2007; Papakonstantinou, Dermatoendocrinol 2012). The visible texture change adults notice in their late thirties is largely this — falling dermal HA is upstream of falling skin volume.
• Oral HA reaches the dermis. Kawada 2014 (Nutr J, 240 mg/d), Oe 2017 (Clin Cosmet Investig Dermatol, 120 mg/d), Hisada 2008 (radiolabeled tracer), and Balogh 2008 (J Agric Food Chem) all showed measurable absorption and skin-tissue accumulation. Topical HA only humidifies the surface (stratum corneum); oral HA is the lever for the deep work.
• Vitamin C is the rate-limiting cofactor for prolyl-4-hydroxylase and lysyl-hydroxylase — the two ascorbate-dependent enzymes that crosslink procollagen into a stable triple helix (Myllyharju 2003, Matrix Biol; Pinnell 1985). Without enough Vitamin C, the collagen you eat or already have can't lock into firm tissue.
• Best for: adults 35+, anyone running a collagen protocol (Marine Collagen, Multi-Collagen Complex, Multi-Collagen Powder), dry-or-crepey skin that doesn't respond to topical-only routines, mild knee or hand-joint discomfort, post-procedure recovery (laser/microneedling), and longevity stackers running a senolytic + NAD⁺ stack who want the structural side covered.
• Timeline: subjective hydration shift 3–4 weeks; visible dermal effect in the 6–8 week window most controlled trials report; structural firmness changes (when stacked with collagen) compound out to 12 weeks and beyond. HA is a daily-input compound, not a stored compound — the dermal pool drains over weeks if you stop.

Why hyaluronic acid sits underneath skin appearance — and how 30 years of biology caught up to the cosmetic claim

Hyaluronic acid (also called hyaluronan, hyaluronate, or HA) is a long-chain glycosaminoglycan (GAG) made of repeating disaccharide units of D-glucuronic acid + N-acetyl-D-glucosamine. It's not a vitamin, not a protein, not a fat — it's a structural sugar polymer your body produces natively in the skin (where it's most concentrated), the synovial fluid of joints, the vitreous humor of the eye, the umbilical cord, and the extracellular matrix of nearly every connective tissue. Karl Meyer first isolated HA from the vitreous body in 1934 (Meyer & Palmer, J Biol Chem). It took another six decades to map the biology, and in the last twenty years that biology has converged on a single conclusion: HA is one of the dominant determinants of visible skin appearance after age 35.

What HA does in skin is functionally simple, anatomically specific, and structurally consequential:

• It holds water in the dermis. The dermal HA-rich extracellular matrix is what gives young skin its bounce, plumpness, and "hydrated from within" appearance. As HA falls, the dermis loses volume, microridges form, and surface texture changes — what we recognize as aging skin is partly the visible signature of falling HA (Papakonstantinou 2012, Dermatoendocrinol; Anderegg 2014, Exp Dermatol).
• It cushions joints. Synovial fluid is roughly 90% HA by mass-fraction of GAGs. Joint-comfort improvement is a documented side benefit of oral HA supplementation (Tashiro 2012, Sci World J; Kalman 2008, Nutr J; Sato 2002).
• It maintains the moisture environment that other dermal proteins need. Collagen and elastin only behave the way they're supposed to in a properly hydrated extracellular matrix. Dry the matrix out and even high-quality collagen synthesis produces brittle, poorly organized fibers. This is the under-appreciated reason that "I'm taking collagen but I don't see anything" stories are so common — the substrate is there, but the matrix isn't hydrated enough to assemble it.
• It signals through CD44 and RHAMM. Beyond the structural water-binding role, HA fragments are bioactive — they bind cell-surface receptors (CD44, RHAMM, TLR4) that regulate keratinocyte migration, fibroblast proliferation, and wound-healing pathways (Toole 2004, Nat Rev Cancer; Stern 2006, Skin Pharmacol Physiol). The signaling biology is one of the reasons HA shows up in wound-healing protocols.
• It maintains intra-tissue water clearance. HA-bound water is osmotically active. The dermal HA pool acts as a moisture buffer that smooths out short-term hydration shocks (climate, sleep, alcohol, illness). When the pool drains with age, day-to-day skin appearance becomes far more sensitive to those inputs — which is why dehydration "shows" more obviously in older skin than in younger skin even at the same fluid intake.

By age 50, total skin HA is roughly half what it was at 20. By 70, it's down by a further 30–50% (Longas 1987, Carbohydr Res; Stern 2007). This decline is upstream of most of the visible hydration loss adults notice in midlife, and it's the lever this capsule targets — not by replacing the dermal pool wholesale (no oral compound does that), but by sustaining a steady supply of HA monomers and small oligomers that the dermal fibroblasts can re-polymerize into native HA via the HAS1/HAS2/HAS3 hyaluronan-synthase enzymes.

Topical vs oral — why both, and why the deep work happens orally

Topical HA serums work, but they work at the surface. The HA molecule in its native form is enormous (1–6 million daltons; a single HA chain in synovial fluid can stretch a meter end-to-end if extended). At that size, intact HA is far too large to cross a healthy epidermis. Topical formulations get around this two ways: they use enzymatically-fragmented low-molecular-weight HA (5–20 kDa, which can penetrate a few cell layers), or they sit on the surface and humidify the stratum corneum by drawing moisture out of the air or out of deeper skin (Pavicic 2011, J Drugs Dermatol). Both are real effects. Both are anatomically limited to the upper micrometers of skin.

Oral HA is a fundamentally different mechanism. Ingested HA is partially digested in the gut by intestinal hyaluronidases and gut microbial enzymes into smaller oligosaccharides (typically tetra- to deca-saccharides), absorbed via paracellular and CD44-mediated routes, and distributed to skin, joints, and connective tissue (Hisada 2008; Kimura 2016, Nutrients; Balogh 2008, J Agric Food Chem). Tracer studies using radiolabeled HA showed measurable accumulation in skin tissue within 24 hours of oral dosing in both rat and human models. The fragments are then re-utilized as substrate by HAS1/HAS2/HAS3 enzymes for de-novo HA synthesis, or they signal directly through dermal CD44 receptors (Galeotti 2018, Front Bioeng Biotechnol).

The topical-vs-oral distinction maps cleanly onto the layers each one reaches:

• Stratum corneum (the outermost ~15 µm): topical HA. Same-day surface hydration, glow, plumpness around eye area within hours. Fades over hours to a day.
• Epidermis (50–150 µm): low-MW topical HA can reach this layer; oral HA can also reach via dermal-to-epidermal diffusion. Effect on barrier function and trans-epidermal water loss.
• Dermis (1.5–4 mm — where the structural change happens): oral HA is the only practical lever. Topical formulations don't reach the dermal fibroblasts in clinically meaningful concentrations. Effect builds over weeks, plateaus at 8–12 weeks, sustains as long as daily intake continues.
• Subcutis / hypodermis: not the primary target of HA-based interventions; volume here is collagen + adipose dependent.

The two approaches don't compete. Topical HA helps with same-day surface hydration; oral HA does the structural work in the dermis. Best-practice skin protocols use both. This product is the oral half of that pair.

Why Vitamin C is paired with HA (and not just an afterthought)

Collagen synthesis has a single chemical bottleneck: hydroxylation. The enzymes prolyl-4-hydroxylase (P4H) and lysyl-hydroxylase (LH) modify proline and lysine residues into hydroxyproline and hydroxylysine. Those modifications are what allow individual procollagen chains to crosslink into a stable triple-helix fiber. Without hydroxylation, you produce procollagen but it never assembles into mature, load-bearing tissue (Myllyharju 2003, Matrix Biol; Pinnell 1985, Yale J Biol Med).

Both enzymes are 2-oxoglutarate-dependent dioxygenases. They require Vitamin C as a redox cofactor — ascorbate keeps the active-site iron in its Fe(II) state, which is what allows the catalytic cycle to turn over. This is not optional — it's why scurvy (severe Vitamin C deficiency) presents as collagen failure: bleeding gums, bruising, slow wound healing, joint pain, hemorrhagic perifollicular hyperkeratosis. The disease is collagen production-line breakdown, made visible. Even at sub-clinical Vitamin C levels (the marginal-deficiency band that's far more common than frank scurvy in modern populations), collagen output drops and the collagen that gets made is structurally compromised (Boyera 1998, Int J Cosmet Sci; Pullar 2017, Nutrients).

For people taking marine or multi-collagen supplements, Vitamin C status is the difference between "I'm taking collagen" and "the collagen I take is actually being assembled into skin." Pairing 100 mg Vitamin C with the 200 mg HA dose addresses both halves of the dermal hydration equation: water-binding capacity (HA) and the structural protein the water is supposed to fill out (Vitamin-C-dependent collagen assembly). The 100 mg dose is the level at which plasma ascorbate saturates collagen-hydroxylation kinetics in fibroblast culture (Boyera 1998); higher doses don't drive more hydroxylation, they just spill into renal excretion (Levine 1999, PNAS).

If you want higher Vitamin C for general antioxidant or immune support, the 100 mg dose here stacks additively with separate ascorbate supplementation — see the Liposomal Vitamin C 1000mg page for the higher-dose option (liposomal encapsulation bypasses the SVCT1 saturable-transport ceiling that limits unencapsulated ascorbate absorption above ~500 mg).

Trial bench — the published evidence at this dose

HA is one of the better-studied beauty-from-within compounds, and the 120–240 mg/day dose range that this product is built around is exactly where the published trials sit. Selected published evidence:

• Kawada 2014 (Nutr J; 60 Japanese adults; 240 mg/day oral HA; 6 weeks): significant improvement in skin moisture and reduction in fine wrinkles vs placebo, measured by corneometer and visual assessment. Endpoint emerged in the 4–6-week window.
• Oe 2017 (Clin Cosmet Investig Dermatol; 60 adults aged 22–59; 120 mg/day; 12 weeks): significant reduction in wrinkle depth and improvement in skin shine and suppleness vs placebo, with both 2 kDa and 300 kDa HA forms demonstrating efficacy.
• Yoshida 2009 (240 mg/day; 12 weeks): increased skin moisture and improved subjective skin condition in dry-skin subjects.
• Hisada 2008 (radiolabeled ¹⁴C-HA tracer in rats): demonstrated absorption of HA fragments into systemic circulation and accumulation in skin within 24h. Earliest direct mechanistic evidence for the oral-HA-reaches-skin claim.
• Balogh 2008 (J Agric Food Chem; ¹⁴C-HA tracer): replicated and extended Hisada with quantitative skin-tissue accumulation kinetics.
• Kimura 2016 (Nutrients): mapped the gut-microbial degradation pathway of HA into the absorbable oligosaccharide fragments.
• Tashiro 2012 (Sci World J; 60 mild knee-OA subjects; 200 mg/day; 12 months): significant improvement in knee-OA symptom scores vs placebo. Joint-comfort endpoint at the same dose this product targets.
• Kalman 2008 (Nutr J; 20 subjects with chronic joint pain; 80 mg/day; 8 weeks): significant pain-score reduction and improved quality-of-life scores.
• Sato 2002 (240 mg/day; knee OA): significant reduction in pain and stiffness scores.
• Oe 2014 (HA 200 mg + glucosamine; knee OA; 12 weeks): symptom-score improvement in mild OA.
• Göllner 2017 (J Evid Based Complementary Altern Med): meta-analytic review of oral HA for skin endpoints — consistent positive effect on hydration and wrinkle depth across 8 RCTs at 120–240 mg/day for 8–12 weeks.

The supporting Vitamin C / collagen literature on the cofactor side is even larger:

• Pullar 2017 (Nutrients) — comprehensive review of Vitamin C in skin biology: ascorbate is concentrated in epidermis (1–10 mM) and dermis (~5 mM), drives collagen synthesis, supports keratinocyte differentiation.
• Boyera 1998 (Int J Cosmet Sci) — fibroblast culture: 50–100 µg/mL ascorbate (100 mg supplemental dose range) is where procollagen synthesis saturates.
• Padayatty 2003 (J Am Coll Nutr) — Vitamin C pharmacokinetics and tissue distribution.
• Levine 1999 (PNAS) — bioavailability ceiling of unencapsulated ascorbate above 200–500 mg/day.
• Carr & Maggini 2017 (Nutrients) — Vitamin C in immune function, wound healing, and connective tissue.
• Cosgrove 2007 (Am J Clin Nutr; ~4,000 women) — higher dietary Vitamin C correlated with lower wrinkle prevalence and reduced skin-dryness odds in a population-level survey.

One pattern across all these studies worth flagging: the 120–240 mg/day HA dose is where measurable endpoints appear. Below 100 mg/day, signal is inconsistent. Above 400 mg/day, no published trial has shown a dose-dependent gain. This is why this product is specifically engineered around 200 mg/cap with 1–2 cap/day flexible dosing — single-cap users hit the trial-tested floor, two-cap users hit the trial-tested ceiling, and you don't pay for a dose that doesn't deliver additional measurable benefit.

What's in each capsule

• Hyaluronic Acid — 200 mg per capsule (pharmaceutical-grade, fermentation-derived from Streptococcus zooepidemicus — vegan, no animal sourcing, mid-molecular-weight optimized for oral absorption; 50–500 kDa is the trial-validated absorption window, balancing fragment-size for paracellular uptake against hyaluronidase resistance).
• Vitamin C — 100 mg as ascorbic acid (collagen-synthesis cofactor for prolyl-4-hydroxylase and lysyl-hydroxylase; 100 mg is the saturating dose for fibroblast collagen-hydroxylation kinetics in published in-vitro work).
• Vegetable cellulose capsule (HPMC) — vegan, no gelatin.
• Third-party tested for purity, microbial limits, heavy metals (USP <232>: Pb <0.5 ppm, As <1.5 ppm, Cd <0.5 ppm, Hg <1.5 ppm), residual solvents (USP <467>), and microbial contamination (USP <2021>). Each lot ships with a Certificate of Analysis (CoA) on request.
• Non-GMO. Manufactured in a cGMP-certified facility.
• No proprietary blends, no artificial colors, no titanium dioxide, no magnesium stearate beyond standard manufacturing trace.
• Allergen-free declaration: no gluten, dairy, soy, egg, peanut, tree nut, shellfish, or fish in this product or in the manufacturing line during this product's runs.

Sourcing, manufacturing, and quality control

Hyaluronic acid quality is dominated by three factors most consumers never see on a label: source organism, molecular weight distribution, and endotoxin / microbial purity.

• Source organism — Streptococcus zooepidemicus, fermentation-derived. Older HA products sourced HA from rooster combs (a slaughterhouse byproduct) — this is where the legacy "HA = animal" association came from. The S. zooepidemicus bacterial-fermentation route, scaled up in the 1990s and 2000s, produces vegan, traceable, batch-uniform HA at higher purity. The original strain produces a polysaccharide capsule that is structurally identical to mammalian HA at the dimer level.
• Molecular-weight distribution — 50–500 kDa target band. Native HA in skin is 1–6 million Da. That size is too large for paracellular gut absorption. Very low MW (<5 kDa) absorbs efficiently but turns over fast and shows pro-inflammatory signaling at the receptor level (Stern 2006). The pharmaceutical-grade HA in this product is QC-targeted to the 50–500 kDa band — the size range most controlled trials have used and the band where absorption is consistent and bioactivity is anti-inflammatory rather than pro-inflammatory.
• Endotoxin / microbial purity. Bacterial-source HA must be purified to remove residual bacterial lipopolysaccharide (LPS), nucleic acids, and protein. This product specifies endotoxin <0.1 EU/mg — well below the limit at which residual LPS would compromise the anti-inflammatory positioning.
• Heavy-metals testing per USP <232> on every lot — Pb, As, Cd, Hg below California Prop-65 thresholds.
• Identity confirmation by HPLC against a USP HA reference standard, plus IR spectroscopy to verify the disaccharide repeat structure.
• Vitamin C identity and assay verified by HPLC (USP <1062>) against an ascorbic-acid reference standard — confirmed at >99% identity per lot.
• UV-protective amber HDPE bottle with foil-induction seal and desiccant. HA is hygroscopic; the desiccant is not optional. Vitamin C is photosensitive; the amber bottle is not optional.
• cGMP-certified facility with full batch records, retain samples, and per-lot CoA.

Comparison to other HA products

The deliberate choice in this product: single-purpose capsule, vegan fermentation-derived HA at the trial-tested dose, paired with the saturating Vit-C cofactor dose, no other ingredients. The capsule is the structural input; you then stack collagen, biotin, astaxanthin, omega-3, and the rest of the foundational layer separately to hit each component's trial-tested dose without compromise.

The complete "beauty from within" stack

HA + Vitamin C is most effective when stacked with the structural protein (collagen), the keratin support (biotin), the membrane-substrate layer (omega-3), and the antioxidant/UV-protection layer (astaxanthin). The clean handoff:

• Marine Collagen 5000 mg — Type I collagen for skin and hair structure. The collagen substrate that the Vitamin C in this capsule helps hydroxylate. Take both daily for the synthesis-cofactor pairing. Marine Collagen Peptides
• Multi-Collagen Complex — Types I, II, III, V, X for skin + joints + gut + bone in capsule form. Multi-Collagen Complex
• Multi-Collagen Powder — same multi-type profile in unflavored 1lb powder for protocols that mix collagen into morning coffee/tea. Multi-Collagen Powder
• Biotin 10,000 mcg — keratin synthesis cofactor for hair and nails; pairs cleanly with HA + collagen for the full hair/skin/nails substrate. Biotin 10,000 mcg
• Liposomal Vitamin C 1000 mg — for general antioxidant/immune use beyond the 100 mg cofactor dose in this capsule, the liposomal form bypasses the SVCT1 absorption ceiling. Doses are additive, not redundant. Liposomal Vitamin C
• Astaxanthin 12 mg — the "internal sunscreen" carotenoid that protects dermal collagen from UV-driven crosslinking damage and lipid peroxidation. The membrane-spanning antioxidant layer that protects the structure HA + collagen + Vit-C just built. Astaxanthin
• Omega-3 Fish Oil 2000 mg — EPA + DHA as the membrane-substrate layer for keratinocyte and fibroblast cell membranes. Skin-barrier function and dermal hydration are partly determined by the omega-3:omega-6 membrane ratio. Omega-3 Fish Oil
• Glutathione 500 mg + NAC 600 mg — the GlyNAC pair for tyrosinase modulation, antioxidant network, and hyperpigmentation support. Glutathione + NAC
• Glycine 1500 mg — completes the GlyNAC triad and supplies a third of the glycine residues collagen requires (collagen is ~33% glycine by mass). Glycine
• NMN 1000 mg + NAD⁺ Daily Boost — the NAD⁺ floor for fibroblast SIRT1 activity and dermal collagen-gene expression. NAD⁺ decline correlates with reduced collagen synthesis with age. NMN 1000mg + NAD+ Daily Boost
• Resveratrol 600 mg + Pterostilbene 100 mg — SIRT1 activator pair for the longevity-stack tie-in. Resveratrol + Pterostilbene
• Curcumin 1000 mg — anti-inflammatory layer for inflammaging skin (UV-driven NF-κB, MMP-1/MMP-9 collagenase suppression). Curcumin + BioPerine
• Vitamin D3 5000 IU + K2 MK-7 — foundational immune/skin-barrier vitamin and the calcium-trafficking cofactor that keeps Vit-D-driven calcium out of dermal vasculature. Vitamin D3 + K2
• Magnesium Glycinate 400 mg — sleep architecture and the cofactor for HA-synthase ATP-dependent steps. Magnesium Glycinate
• Beauty & Longevity Stack — the bundled discount on Marine Collagen + Biotin + this Hyaluronic Acid product (the three-pack the trials would call the canonical beauty-from-within combination). Beauty & Longevity Stack

Read more in Marine Collagen for Hair Growth, Hyaluronic acid for skin: topical vs oral, and browse the Beauty & Collagen collection.

What to expect — week-by-week timeline

• Weeks 1–2: usually nothing visible. The dermal HA pool is starting to refill but hasn't reached the threshold for a visible/tactile change. This is the "is it working?" phase that most users abandon — don't.
• Weeks 3–4: skin starts feeling less tight after cleansing and in dry climates. Subtle plumpness around the eye area and along the lower cheek for some users. If you stack with collagen + biotin, hair-shaft strength may start showing in the same window.
• Weeks 6–8: visible hydration improvement, especially in skin that previously looked dry, crepey, or dehydrated. This is the window most controlled trials report measurable change (Kawada 2014, Oe 2017). Joint-comfort improvements (knees, hands, fingers) often arrive in the same window if present (Tashiro 2012).
• Weeks 8–12: sustained dermal hydration that persists across day-to-day climate, sleep, and alcohol fluctuations. If you're stacking with collagen + Vit-C cofactor + biotin + omega-3, the synthesis effect compounds — firmness improvements typically arrive in this window.
• Months 3–6: the dermal HA-collagen-keratin substrate is fully replenished and the daily intake maintains it at the new steady-state level. Subjective and objective endpoints plateau — additional intake doesn't improve them, but daily intake is required to maintain them.
• Year 1+: with sustained daily intake plus the foundational stack (NMN + omega-3 + Vit-D + Mg), the dermal-hydration setpoint stays elevated relative to age-matched controls. Population-level data (Cosgrove 2007) suggests this maps onto reduced wrinkle prevalence over years, though this is correlation in observational data, not causation in a controlled trial.
• If you stop: the dermal HA pool drains over weeks. The structural effect is maintained by daily intake, not stored long-term. Most users notice the rebound at 4–6 weeks after cessation — about the same timeline as the build-up phase, which is what you'd expect for a tissue-pool-based effect.

What NOT to expect: overnight skin transformation, "filler-like" volume restoration (that's an injection-only effect at orders-of-magnitude higher localized dose), reversal of UV/photoaging damage that's already occurred at the elastin-fragmentation level, or replacement of structural skincare like sunscreen and topical retinoid. HA + Vit-C is a substrate-and-cofactor input. It builds the matrix; it doesn't undo years of accumulated photodamage.

Who this is for

• Adults 35+ where natural HA stores have noticeably dropped (the "where did my plumpness go" age band — typically late 30s to mid-40s for first noticeable shift).
• Anyone taking Marine Collagen 5000 mg, Multi-Collagen Complex, or Multi-Collagen Powder who needs the Vit-C cofactor and the dermal-hydration substrate to make sure the collagen they're paying for actually gets assembled.
• People with persistently dry, crepey, or dehydrated skin that doesn't respond to topical-only routines.
• Joint-comfort users — HA is in synovial fluid and oral supplementation has demonstrated knee-OA and hand-joint comfort improvements at the 80–240 mg/day dose range (Tashiro 2012, Kalman 2008).
• Post-procedure recovery — laser resurfacing, microneedling, dermabrasion, fractional CO2: oral HA + Vit-C supports the dermal-rebuild phase. (Ask your dermatologist before adding any supplement post-procedure.)
• Adults running a structured beauty-from-within protocol who want the simplest possible add: one bottle, two daily capsules, both ingredients backed by trials at the dose used.
• Vegans and vegetarians — both the HA (fermentation-derived) and the capsule (HPMC) are vegan.
• Longevity stackers running NMN + resveratrol + senolytics who want the structural-skin layer covered alongside the cellular-aging layer.

Who this is not for

• Anyone expecting same-week visible change. HA is a structural compound — the timeline is 6–12 weeks. If your time horizon is shorter than that, this isn't the right product.
• Active cancer or in chemotherapy. Some tumor types overexpress CD44 (an HA receptor), and the literature on whether oral HA could be permissive vs neutral in those contexts is unsettled (Toole 2004; Misra 2015). Consult your oncologist before adding HA-based supplementation. The conservative default is to defer HA supplementation during active treatment.
• Pregnancy or breastfeeding. Not because HA is dangerous, but because there isn't enough trial data in pregnant or lactating populations to set a confident safety profile. Default to caution and consult your OB/GYN.
• Severe iron-overload conditions — hereditary hemochromatosis, repeated transfusion-dependent populations, or anyone with documented elevated ferritin under physician supervision. Vitamin C (the 100 mg dose in this capsule) increases non-heme iron absorption. Discuss before starting.
• Calcium-oxalate kidney-stone history. High-dose Vit-C (>1 g/day) is associated with oxalate stone formation in susceptible people. The 100 mg/cap dose here is well below that range, but flag with your physician if you have a history.
• Anyone with a documented HA allergy. Rare, but possible. Discontinue if you develop rash, GI symptoms, or pruritus in the first 1–2 weeks.
• Children under 18. Trial data is in adults; pediatric use is outside the published evidence base.

How to take it

Take 1–2 capsules daily with water. The trial-tested daily HA dose is 120–240 mg, which fits inside this product's 200–400 mg/day range depending on whether you take 1 or 2 capsules:

• 1 capsule/day — 200 mg HA + 100 mg Vit-C. Sits within the published trial dose band; appropriate for hydration-priority and for combined collagen-stacker use where Vit-C is the cofactor target.
• 2 capsules/day — 400 mg HA + 200 mg Vit-C. Sits at the upper end of the published trial range; appropriate for joint-comfort priority, post-procedure use, and the deeper dermal-hydration window for severely dry/crepey skin.
• Best with breakfast. HA absorption isn't strictly food-dependent, but pairing with the morning longevity stack and a collagen scoop makes daily compliance much easier.
• Daily consistency matters far more than dose timing. Skin HA turnover happens over days; missing the occasional dose is fine, but skipping multiple days a week erodes the cumulative effect.
• Missed dose: take it when you remember (same-day) or skip and resume the next morning. Don't double-dose.
• Cycling not required. All published trials run continuous-daily for 8–24 weeks. There's no pharmacological rationale for cycling oral HA.
• Travel: the bottle is shelf-stable at room temperature; no refrigeration needed. Tropical or hot-climate travel: keep below 30°C / 86°F if possible.

Safety, contraindications, and interactions

• Pregnancy / breastfeeding — insufficient trial data; default to caution and consult an OB/GYN.
• Active cancer / chemotherapy — CD44/RHAMM HA-receptor biology is unsettled in some tumor contexts. Discuss with your oncologist before starting any HA supplement.
• Hemochromatosis or iron overload — ascorbic acid increases non-heme iron absorption. Discuss the 100 mg/day Vit-C dose with your physician.
• Kidney stones (calcium oxalate) — high-dose Vit-C (>1 g/day) is associated with oxalate stone formation in susceptible people. The 100 mg/cap dose here is well below that range, but flag a stone history with your physician.
• HA allergy — rare, but possible. Discontinue if rash, GI symptoms, or pruritus develop in the first week.
• Anticoagulants (warfarin, apixaban, rivaroxaban): high-dose Vit-C (>1 g/day) can theoretically influence INR. The 100 mg/day dose in this capsule is well below that range, but mention any new supplement to your prescribing physician.
• No known interactions with NMN, resveratrol, collagen, biotin, omega-3, magnesium, ashwagandha, berberine, ALA, CoQ10, or the rest of the True Health Protocol Longevity Essentials stack.
• No known interactions with topical retinoids, AHAs, BHAs, peptides, or Vit-C serums — they act at completely different anatomical layers.

FAQ

Is oral HA actually different from topical? Yes — mechanistically and anatomically. Topical HA hydrates the stratum corneum (the surface, ~15 µm). Oral HA reaches the dermis (the deep skin layer, 1.5–4 mm down, where structural change happens). Use both if your goal is full-coverage hydration; use oral if you want the dermal-volume effect that topicals can't achieve. They aren't competitors — they target different layers.

Why 200 mg HA per capsule and not 50 mg or 500 mg? The published trials hit measurable skin and joint endpoints at 120–240 mg/day (Kawada 2014; Oe 2017; Tashiro 2012). 50 mg/day formulations are sub-trial-dose. 500+ mg/day adds cost without published evidence of additional benefit. 200 mg/cap puts a single cap at the low end of the trial range and 2 caps at the high end — flexible dosing without overshooting.

Why pair HA with Vitamin C, and not just take Vitamin C with collagen instead? You can do both. The Vitamin-C-as-collagen-cofactor mechanism applies to whatever collagen synthesis is happening — whether the substrate is dietary protein, supplemented collagen peptides, or your own body's collagen production. Pairing in the HA capsule simply guarantees the cofactor is present in every dose. If you're also taking Liposomal Vitamin C for general antioxidant use, the doses are additive and complementary.

Can vegans take this? Yes. The HA in this product is fermentation-derived from a bacterial source (Streptococcus zooepidemicus), not from rooster combs (the older, animal-sourced HA). The capsule shell is vegetable cellulose (HPMC). No animal-derived inputs anywhere in the product.

Will it help with joint pain? Possibly — oral HA has documented joint-comfort effects in mild knee OA and hand-joint discomfort (Tashiro 2012, Kalman 2008, Sato 2002, Oe 2014). The dose range tested (80–240 mg/day) overlaps the dose in this product. It's not a replacement for medical care, but it's a reasonable side benefit if you're taking it for skin reasons.

Does it interact with retinol or other topical actives? No. Oral HA + Vit-C and topical retinoids/AHAs/BHAs/peptides act at completely different layers of the skin. They are complementary, not competitive. Best-practice protocols use both.

What about HA molecular weight — does it matter? Yes, somewhat. Very high MW HA (1M+ Da) doesn't absorb well orally. Very low MW HA (<5 kDa) absorbs better but turns over fast and shows pro-inflammatory CD44/TLR4 signaling at the receptor level (Stern 2006). Mid-molecular-weight HA (50–500 kDa, the QC-target band in this product) is the size most controlled trials have used for oral skin endpoints — the absorption-friendly band that retains anti-inflammatory rather than pro-inflammatory bioactivity.

Why not HA + collagen in one capsule? Collagen requires gram-level dosing (5,000 mg/day is the trial-tested range) which doesn't fit in a capsule format — that's why our collagen products are powders or 240-cap bottles. HA is dosed in milligrams, so capsule format works. The right architecture is HA in caps + collagen in a powder or larger cap pack, taken together.

Can I take HA alongside NMN 1000mg and the longevity stack? Yes. There are no known interactions between HA + Vit-C and NMN, resveratrol, pterostilbene, fisetin, quercetin, apigenin, urolithin A, spermidine, or any of the rest of the longevity-stack products. Many users take HA + Vit-C as the structural-skin layer alongside the cellular-aging layer.

Does HA help with hair growth? Indirectly. The dermal-hydration effect supports the follicular microenvironment, and HA is part of the dermal papilla extracellular matrix that surrounds growing hair follicles. The direct hair-growth substrate is collagen + biotin (see Biotin 10,000 mcg); HA is supportive rather than primary.

Is rooster-comb HA the same as fermentation-derived? Chemically very similar at the disaccharide level, but rooster-comb HA is animal-sourced (slaughterhouse byproduct), has more batch-to-batch variability in molecular weight, and carries a small risk of avian protein contamination. Fermentation-derived HA from S. zooepidemicus is vegan, batch-uniform, and the form used in nearly all post-2010 published clinical trials. This product uses the fermentation-derived form.

Can I take it long-term? Yes. Multi-year safety data is favorable; HA is a compound your body makes natively and turns over continuously. Tashiro 2012 ran daily HA for 12 months without safety issues. The cycling-not-required note above applies: trial protocols are continuous-daily.

Does it raise blood sugar? No. HA is a glycosaminoglycan, not a free sugar — it doesn't raise blood glucose, doesn't trigger an insulin response, and is appropriate for diabetic and metabolic-syndrome users. The 100 mg ascorbic-acid dose is also well below the threshold where Vit-C might affect glucose-meter readings (a documented but high-dose phenomenon at >1 g/day).

Should I take it on an empty stomach or with food? Either works. HA absorption is not strongly food-dependent. The Vit-C side absorbs slightly better with a small amount of food (gentler on the stomach for users prone to ascorbate-induced gastric discomfort). Default to "with breakfast" for daily-compliance reasons rather than absorption reasons.

Time to effect? Hydration shift typically appears at 6–8 weeks of daily intake. Joint comfort, if present, often appears in the same window. Structural firmness changes (when stacking with collagen) compound out to 12 weeks and beyond. If you've been on the protocol for 12 weeks at 1–2 caps/day with no perceptible change, troubleshoot the rest of the stack — Vit-C status, collagen substrate, omega-3 membrane-substrate, sleep, hydration baseline — before increasing the HA dose.

How does this compare to HA injectables / fillers? Fundamentally different intervention. Injectables deliver 10–20 mg/cc of cross-linked HA into a specific anatomical site for localized volume restoration that lasts 6–18 months. Oral HA delivers daily structural substrate to the entire dermis and other connective tissues; it can't recreate the localized-volume effect of an injectable, but it can support dermal-pool homeostasis system-wide and complement (not replace) injectable protocols if you do those.

Will it help with stretch marks or scars? Limited direct evidence. HA + Vit-C supports dermal substrate and collagen synthesis, which is relevant to wound-healing and tissue-remodeling biology, but mature stretch marks and scars are dermal architecture changes that don't fully reverse with any oral supplement. The stack-plus-time approach (oral HA + collagen + Vit-C + topical retinoid + sun protection) is a reasonable long-game protocol; expectations should be modest.

Does it help with eye dryness? Some evidence — vitreous humor is HA-rich, and oral HA has been studied for tear-film and dry-eye endpoints (Yoshida 2014; small trials, mixed results). It's not the primary use case for this product, but several users report subjective eye-comfort improvements. If eye dryness is your primary concern, omega-3 supplementation (Omega-3 Fish Oil) has stronger trial evidence for that specific endpoint.

Storage? Cool, dry, dark. Don't refrigerate (condensation can compromise the HA's hygroscopic properties). The amber HDPE bottle and desiccant are doing their job — keep the cap tight and don't transfer to a daily pill organizer for more than ~2 weeks at a time.

Where this sits in the True Health Protocol catalog

Hyaluronic Acid 200 mg + Vit-C 100 mg is the structural-skin / dermal-hydration anchor in the catalog. It's the small-molecule water-binding and collagen-cofactor input layer of the four-layer beauty-from-within architecture:

1. Substrate — collagen peptides (Marine Collagen, Multi-Collagen Complex, Multi-Collagen Powder), keratin support (Biotin).
2. Cofactor + hydration — this product: HA + Vit-C.
3. Antioxidant + photoprotection — Astaxanthin, Glutathione + NAC, Curcumin, Liposomal Vit-C for higher antioxidant doses.
4. Membrane + foundational — Omega-3, Vit-D3 + K2, Mg-Glycinate.

The Beauty & Longevity Stack bundle pre-packages layers 1 + 2 (collagen + biotin + this HA+Vit-C product) at a discount — that's the trial-validated minimum-viable beauty-from-within combination. Layers 3 + 4 are added a-la-carte from the broader catalog as the longevity-stack alongside NMN 1000mg, Resveratrol, CoQ10, and the rest of the longevity foundation.

Selected references

• Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934;107:629–34. (Original HA isolation.)
• Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol 2008;26(2):106–22.
• Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003;13(12):105R–115R.
• Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006;85(8):699–715.
• Stern R. Hyaluronan in cancer biology. Semin Cancer Biol 2008;18(4):238–43.
• Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol 2012;4(3):253–8.
• Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004;4(7):528–39.
• Longas MO, Russell CS, He XY. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res 1987;159(1):127–36.
• Anderegg U, Simon JC, Averbeck M. More than just a filler — the role of hyaluronan for skin homeostasis. Exp Dermatol 2014;23(5):295–303.
• Kawada C, Yoshida T, Yoshida H, Matsuoka R, Sakamoto W, Odanaka W, Sato T, Yamasaki T, Kanemitsu T, Masuda Y, Urushibata O. Ingested hyaluronan moisturizes dry skin. Nutr J 2014;13:70.
• Oe M, Sakai S, Yoshida H, Okado N, Kaneda H, Masuda Y, Urushibata O. Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period. Clin Cosmet Investig Dermatol 2017;10:267–73.
• Yoshida T, Kawada C, Yamasaki T, Sakamoto W, Odanaka W, Sato T, Kobayashi Y. Effect of hyaluronic acid intake on dry skin. Aesthetic Dermatology 2009;19:227–37.
• Hisada N, Satsu H, Mori A, Totsuka M, Kamei J, Nozawa T, Shimizu M. Low-molecular-weight hyaluronan permeates through human intestinal Caco-2 cell monolayers via the paracellular pathway. Biosci Biotechnol Biochem 2008;72(4):1111–4.
• Balogh L, Polyak A, Mathe D, Kiraly R, Thuroczy J, Terez M, Janoki G, Ting Y, Bucci LR, Schauss AG. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem 2008;56(22):10582–93.
• Kimura M, Maeshima T, Kubota T, Kurihara H, Masuda Y, Nomura Y. Absorption of orally administered hyaluronan. J Med Food 2016;19(12):1172–9.
• Galeotti F, Bertini S, Crescenzi V, et al. Bioactivities of low-molecular-weight hyaluronan oligomers. Front Bioeng Biotechnol 2018;6:115.
• Tashiro T, Seino S, Sato T, Matsuoka R, Masuda Y, Fukui N. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis. Sci World J 2012;2012:167928.
• Kalman DS, Heimer M, Valdeon A, Schwartz H, Sheldon E. Effect of a natural extract of chicken combs with a high content of hyaluronic acid on pain relief and quality of life in subjects with osteoarthritis: a pilot study. Nutr J 2008;7:3.
• Sato T, Iwaso H. An effectiveness study of hyaluronic acid in the treatment of osteoarthritis of the knee. Aesthetic Surg J 2002;9(3):260–7.
• Oe M, Mitsugi K, Odanaka W, Yoshida H, Matsuoka R, Seino S, et al. Dietary hyaluronic acid migrates into the skin of rats. Sci World J 2014;2014:378024.
• Göllner I, Voss W, von Hehn U, Kammerer S. Ingestion of an oral hyaluronan solution improves skin hydration, wrinkle reduction, elasticity, and skin roughness: results of a clinical study. J Evid Based Complementary Altern Med 2017;22(4):816–23.
• Pavicic T, Gauglitz GG, Lersch P, Schwach-Abdellaoui K, Malle B, Korting HC, Farwick M. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol 2011;10(9):990–1000.
• Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol 2003;22(1):15–24.
• Pinnell SR. Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J Biol Med 1985;58(6):553–9.
• Boyera N, Galey I, Bernard BA. Effect of vitamin C and its derivatives on collagen synthesis and cross-linking by normal human fibroblasts. Int J Cosmet Sci 1998;20(3):151–8.
• Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients 2017;9(8):866.
• Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 2003;22(1):18–35.
• Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001;98(17):9842–6.
• Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017;9(11):1211.
• Cosgrove MC, Franco OH, Granger SP, Murray PG, Mayes AE. Dietary nutrient intakes and skin-aging appearance among middle-aged American women. Am J Clin Nutr 2007;86(4):1225–31.
• Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 2015;6:201.

This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.